Mirae Asset Global Etfs Holdings »

Vor Biopharma shares owned by Mirae Asset Global Etfs Holdings

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Mirae Asset Global Etfs Holdings from 13F filings

Historical chart of Mirae Asset Global Etfs Holdings investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Mirae Asset Global Etfs Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $52k 3.5k 14.70

More positions owned by Mirae Asset Global Etfs Holdings

NVIDIA Corporation (NVDA)
Cameco Corporation (CCJ)
Apple (AAPL)
Wheaton Precious Metals Corp (WPM)
Global X Fds X Russell 2000 E (RSSL)
Microsoft Corporation (MSFT)
Palantir Technologies Cl A (PLTR)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Lockheed Martin Corporation (LMT)
Tesla Motors (TSLA)
Pan American Silver Corp Can (PAAS)
Meta Platforms Cl A (META)
Raytheon Technologies Corp (RTX)

View all positions for Mirae Asset Global Etfs Holdings

Top funds holding Vor Biopharma

TCG Crossover Management
RA Capital Management
Fcpm Iii Services B.v.
VR Adviser
Frazier Life Sciences Management
FMR
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Vanguard Capital Management
Susquehanna International
Caligan Partners
BlackRock
Vanguard Group
Logos Global Management
Boothbay Fund Management

View all funds holding Vor Biopharma